Tatiana A Reimer

Summary

Country: Germany

Publications

  1. pmc Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
    Tatiana A Reimer
    Department of Hematology, Oncology and Tumorimmunology, Max Delbruck Center for Molecular Medicine, Berlin, Germany
    BMC Cancer 5:47. 2005
  2. doi request reprint Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells
    Jana Wolf
    Department of Haematology, Oncology and Tumorimmunology, Max Delbruck Center for Molecular Medicine, Robert Rossle Str 10, 13125 Berlin, Germany
    FASEB J 24:4000-19. 2010

Collaborators

  • Armin Rehm
  • Jana Wolf
  • Constantin Rüder
  • Eva Christina Müller
  • Sebastian Schuck
  • Bernd Dorken
  • Albrecht Otto
  • Kerstin Gerlach

Detail Information

Publications2

  1. pmc Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
    Tatiana A Reimer
    Department of Hematology, Oncology and Tumorimmunology, Max Delbruck Center for Molecular Medicine, Berlin, Germany
    BMC Cancer 5:47. 2005
    ..This raised the question if EBAG9 is tumor-specific and mediates apoptosis itself or through O-linked glycans generated, among them the cognate 22-1-1 antigen Tn...
  2. doi request reprint Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells
    Jana Wolf
    Department of Haematology, Oncology and Tumorimmunology, Max Delbruck Center for Molecular Medicine, Robert Rossle Str 10, 13125 Berlin, Germany
    FASEB J 24:4000-19. 2010
    ....